Flexion Therapeutics, Inc. Debt to Equity Ratio 2014-2021 | FLXN
Current and historical debt to equity ratio values for Flexion Therapeutics, Inc. (FLXN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Flexion Therapeutics, Inc. debt/equity for the three months ending September 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-09-30 | $0.30B | $-0.08B | -3.65 |
| 2021-06-30 | $0.27B | $-0.06B | -4.74 |
| 2021-03-31 | $0.27B | $-0.04B | -6.93 |
| 2020-12-31 | $0.27B | $-0.02B | -16.12 |
| 2020-09-30 | $0.27B | $-0.00B | -86.09 |
| 2020-06-30 | $0.26B | $0.02B | 15.46 |
| 2020-03-31 | $0.26B | $-0.05B | -4.91 |
| 2019-12-31 | $0.24B | $-0.02B | -11.82 |
| 2019-09-30 | $0.24B | $0.01B | 33.07 |
| 2019-06-30 | $0.19B | $0.04B | 4.61 |
| 2019-03-31 | $0.19B | $0.07B | 2.65 |
| 2018-12-31 | $0.19B | $0.11B | 1.69 |
| 2018-09-30 | $0.19B | $0.15B | 1.27 |
| 2018-06-30 | $0.18B | $0.19B | 0.95 |
| 2018-03-31 | $0.17B | $0.22B | 0.78 |
| 2017-12-31 | $0.18B | $0.26B | 0.70 |
| 2017-09-30 | $0.18B | $0.17B | 1.02 |
| 2017-06-30 | $0.17B | $0.20B | 0.84 |
| 2017-03-31 | $0.04B | $0.17B | 0.23 |
| 2016-12-31 | $0.04B | $0.19B | 0.21 |
| 2016-09-30 | $0.04B | $0.14B | 0.26 |
| 2016-06-30 | $0.02B | $0.15B | 0.14 |
| 2016-03-31 | $0.02B | $0.09B | 0.26 |
| 2015-12-31 | $0.02B | $0.10B | 0.22 |
| 2015-09-30 | $0.02B | $0.12B | 0.19 |
| 2015-06-30 | $0.01B | $0.13B | 0.05 |
| 2015-03-31 | $0.00B | $0.14B | 0.03 |
| 2014-12-31 | $0.01B | $0.15B | 0.06 |
| 2014-09-30 | $0.01B | $0.06B | 0.14 |
| 2014-06-30 | $0.01B | $0.07B | 0.11 |
| 2014-03-31 | $0.01B | $0.07B | 0.12 |
| 2013-12-31 | $0.01B | $0.01B | 0.86 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
